Propanc Biopharma gets advance overseas finding from BIS Australia

Australia |  News | 0 Comment | 22 Jan, 2020

Australia based Propanc Biopharma, Inc., a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced that a Certifica...Read more

3B Scientific to acquire iSimulate

Australia |  News | 0 Comment | 21 Jan, 2020

Germany based 3B Scientific, a portfolio company of J.H. Whitney Capital Partners, LLC and the world's leading manufacturer and marketer of anatomical models and medical simulation pro...Read more

International research collaboration reveals treatment of leukemia

Australia |  News | 0 Comment | 20 Jan, 2020

International research collaboration between the United States and Australia has revealed a promising new drug that could treat high-risk leukemia. US based OncoTartis,...Read more

InterVenn Biosciences advances glycoproteomics for complex disease therapies

Australia |  News | 0 Comment | 17 Jan, 2020

US based InterVenn Biosciences has announced multiple achievements in its development of AI-enabled glycoproteomics, as it looks to solving difficult challenges in various disease areas of ...Read more

AVROBIO announces clinical and regulatory progress for Gaucher Disease Program

Australia |  News | 0 Comment | 17 Jan, 2020

US based AVROBIO, a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, has received notice of clearance from the U.S. Food and Dru...Read more

Agilex Biolabs announces new pharmacodynamics services

Australia |  News | 0 Comment | 15 Jan, 2020

Award-winning Agilex Biolabs, the Asia-Pacific region’s leading bioanalytical laboratory based in Australia, announced a raft of new pharmacodynamics services for biotech and pha...Read more

Australia explores novel way to detect infections and cancers

Australia |  News | 1 Comment | 13 Jan, 2020

Melbourne researchers have determined the molecular basis for how an important component of the immune system, called gamma-delta T cells, detects infections and cancers. The research team...Read more

Griffith University to develop new drug for parainfluenza virus

Australia |  News | 0 Comment | 06 Jan, 2020

Australia based Griffith University’s Institute for Glycomics has partnered with Hong Kong listed China Grand Pharma’s newly established Australian company Grand Medic...Read more

AlayaCare acquires Procura to strengthen its healthcare platform

Australia |  News | 0 Comment | 03 Jan, 2020

AlayaCare, an award-winning technology platform for home and community care, has announced the acquisition of Procura, a division of Complia Health, a leading global provider of enterprise ...Read more

Avita Medical gets FDA approval for Recell device

Australia |  News | 0 Comment | 03 Jan, 2020

UK based AVITA Medical Limited, a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration has announced that the U...Read more

Genetic data offers risk indications for ischaemic stroke

Australia |  News | 0 Comment | 01 Jan, 2020

A group of investigators from Australia, Germany, and the UK have shown that genetic data obtained from a single blood draw or saliva sample can be used to identify individuals at a 3-fold ...Read more

Adelaide researchers to develop novel Zika vaccine

Australia |  News | 0 Comment | 30 Dec, 2019

Researchers from the University of Adelaide, Australia have made significant advances in developing a novel vaccine against Zika virus, which could potentially lead to global elimination of...Read more

Investors inject $45M into South Australia biotech industry

Australia |  News | 0 Comment | 27 Dec, 2019

The Adelaide China Biotech Investment Fund has been launched – a new $45 million investment fund that will accelerate the development and commercialisation of health and bio-technolog...Read more

Glenmark announces approval for Ryaltris in Australia

Australia |  News | 0 Comment | 23 Dec, 2019

Glenmark Pharmaceuticals has announced that Seqirus Pty. Ltd. (Seqirus) has received marketing approval for Ryaltris® from the Therapeutic Goods Administration (TGA), Australia. This pa...Read more

Australia's MRCF leads $8.8M funding for Pathios Therapeutics

Australia |  News | 0 Comment | 20 Dec, 2019

UK based Pathios Therapeutics Limited, an innovative biotech company focused on the development of first-in-class therapies for autoimmune diseases and cancer, has announced a US$8.8M Serie...Read more

Biocon & Equillium expand collaboration to Australia, NZ

Australia |  News | 0 Comment | 13 Dec, 2019

India headquartered Biocon Ltd and US based Equillium Inc., a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimm...Read more

NeuClone announces Positive Ph I results of Herceptin® (Trastuzumab) Biosimilar

Australia |  News | 0 Comment | 13 Dec, 2019

NeuClone Pharmaceuticals Ltd, a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products, on 5 Dec 2019, announced that NeuCeptin, a biosi...Read more

Mainstay Medical receives approval for ReActiv8 from Australian TGA

Australia |  News | 0 Comment | 11 Dec, 2019

Ireland based medical device company Mainstay Medical International plc has announced that it has received regulatory approval from the Australian Therapeutic Goods Administration (TGA) for...Read more